Digital Health Global

SEPTEMBER 28, 2023

Investments will focus on the next generation of pharma R&D to accelerate drug development, on new technology solutions enabling a more patient-centric approach in clinical trials, and on digital platforms uncovering new insights from clinical data for more personalized care pathways.

Drug Development 88

Drug Development Pharmaceuticals Digital Health Life Science 88

Lloyd Price

JUNE 17, 2023

Teladoc quickly grew, and by 2006 it was providing services to over 100,000 patients. As the ability to collect and analyze large amounts of patient data grows, there is a growing opportunity for companies to develop personalized treatments and care plans. Byron Brooks EE MD and Michael Gorton. In 2013, Teladoc went public on the NYSE.

Digital Health 81

Digital Health Drug Development Telemedicine Telehealth 81

Digital Health Global

NOVEMBER 20, 2023

We believe Evinova’s combination of scientific expertise and track record in developing AI-enabled digital technologies at scale, provides a real opportunity to fundamentally improve patient care, drive healthcare transformation and reduce carbon emissions.” 2 Digital health is a large (+$900bn by 2032) and growing (13.6%

Life Science 88

Life Science Digital Health Drug Development Patient Experience 88